BRAF and thyroid gland carcinoma: Recently, the RAS-RAF-MAP kinase signaling pathway has been implicated in many cancers, particularly more frequently in thyroid carcinomas, with the BRAF V600E mutation playing a vital role in papillary thyroid carcinoma.